微譜聚焦化學藥品領域，致力于成為行業值得信賴的醫藥研發伙伴。我們密切關注全球醫藥領域發展趨勢，整合出藥包材及生產系統研究、化學藥品質量研究、化學藥品藥學及臨床研究等多平臺服務，以完備的質量體系、高速的交付周期、豐富的項目經驗及持續擴張的能力布局。2024年5月，微譜藥物及醫療器械實驗室成功通過美國FDA現場核查。我們的報告得到了中國、歐盟、美國、WHO等國際主要市場監管機構的認可，成功助力3500余家藥物及醫療器械企業加速產品上市進程！ 

WEIPU focuses on the chemical pharmaceuticals field, committed to becoming a trusted partner in pharmaceutical R&D for the industry. We closely monitor global trends in pharmaceutical development and have integrated multi-platform services including:  Pharmaceutical packaging materials and production system research,Chemical drug quality studies,Pharmaceutical development studies, Clinical research services.

Supported by a comprehensive quality system, accelerated delivery cycles, extensive project experience (3,500+ completed cases), and continuously expanding capabilities, we provide end-to-end solutions.  In May 2024, WEIPU's Pharmaceuticals and Medical Devices Laboratory successfully passed an on-site inspection by the U.S. FDA. Our technical reports have been recognized by major global regulatory authorities including China NMPA, EU EMA, U.S. FDA, and WHO, accelerating product commercialization for over 3,500 pharmaceutical and medical device companies.